Patents Assigned to The J. David Gladstone Institutes, a Teatamentary Trust Established Under the Will of J. David. Gladstone
  • Methods for treatment of retinal disease by photoreceptor gene expression modulation
    Patent number: 10849904
    Abstract: Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: December 1, 2020
    Assignees: University of Washington, The J. David Gladstone Institutes, a Teatamentary Trust Established Under the Will of J. David. Gladstone
    Inventors: Thomas A. Reh, Paul Nakamura, Sheng Ding